FORM 4
[ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).         
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP OF SECURITIES
                                                                                  
OMB APPROVAL
OMB Number: 3235-0287
Expires: February 28, 2011
Estimated average burden
hours per response... 0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public
Utility Holding Company Act of 1935 or Section 30(f) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

HERREGRAVEN MARC 		2. Issuer Name and Ticker or Trading Symbol

UROPLASTY INC [ UPI ] 		5. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                      _____ 10% Owner
__ X __ Officer (give title below)      _____ Other (specify below)
VP Manufacturing
(Last)          (First)          (Middle)

5420 FELTL RD 		3. Date of Earliest Transaction (MM/DD/YYYY)

6/8/2010
(Street)

MINNETONKA, MN 55343
(City)        (State)        (Zip)
4. If Amendment, Date Original Filed (MM/DD/YYYY)

 
6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3) 		2. Trans. Date 2A. Deemed Execution Date, if any 3. Trans. Code
(Instr. 8) 		4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4) 		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4) 7. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V Amount (A) or (D) Price
common stock   6/8/2010     A    5100   A $0   13200   (1) D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 3) 		2. Conversion or Exercise Price of Derivative Security 3. Trans. Date 3A. Deemed Execution Date, if any 4. Trans. Code
(Instr. 8) 		5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5) 		6. Date Exercisable and Expiration Date 7. Title and Amount of Securities Underlying Derivative Security
(Instr. 3 and 4) 		8. Price of Derivative Security
(Instr. 5) 		9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4) 10. Ownership Form of Derivative Security: Direct (D) or Indirect (I) (Instr. 4) 11. Nature of Indirect Beneficial Ownership (Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
employee non-qualified stock options   $2.85                    2/2/2006   (2) 2/2/2011   Common Stock   20000     20000   D    
employee non-qualified stock options   $2.65                    2/2/2008   (2) 2/1/2014   Common Stock   5000     5000   D    
employee non-qualified stock options   $4.31                    7/3/2007   (2) 7/2/2012   Common Stock   20000     20000   D    
employee non-qualified stock options   $3.15                    6/24/2008   (2) 6/23/2013   Common Stock   20000     20000   D    
employee non-qualified stock options   $0.85                    6/5/2009   (2) 6/4/2014   Common Stock   30000     30000   D    
employee non-qualified stock options   $4.94   6/8/2010     A      6525       6/8/2011   (2) 6/7/2017   Common Stock   6525   $0   6525   D    

Explanation of Responses:
( 1)  Includes 5,100 shares of restricted stock subject to risk of forfeiture that lapses with respect to one fourth of such shares on each of the first, second, third and fourth anniversaries of the grant date (June 8, 2010).
( 2)  Becomes exercisable with respect to one-third of the shares on such date, and an additional, cumulative one-third on the first and second anniversary of such date.

Remarks:
Signature is on behalf of Mr. Herregraven

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
HERREGRAVEN MARC
5420 FELTL RD
MINNETONKA, MN 55343

VP Manufacturing

Signatures
Larry Bakeman 6/10/2010
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
Uroplasty (AMEX:UPI)
Historical Stock Chart
From Mar 2024 to Apr 2024 Click Here for more Uroplasty Charts.
Uroplasty (AMEX:UPI)
Historical Stock Chart
From Apr 2023 to Apr 2024 Click Here for more Uroplasty Charts.